| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.043 | 0.4 |